Here Come the Appeals ...
BMS is the first on what's bound to be a long list of opponents in the recent ruling on the definition of "average wholesale price."
It's Not What It Looks Like
Genentech says Tanox acquisition does not signal a shift in strategy.
Pharma Defensive After Dem's Victory
Industry points to new reports on Part D to blunt new Congressional critics.
